These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 20033305)

  • 1. Use of memantine (akatinol) for the correction of cognitive impairments in Parkinson's disease complicated by dementia.
    Litvinenko IV; Odinak MM; Mogil'naya VI; Perstnev SV
    Neurosci Behav Physiol; 2010 Feb; 40(2):149-55. PubMed ID: 20033305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Memantine (akatinol) therapy of cognitive impairment in Parkinson's disease complicated by dementia].
    Litvinenko IV; Odinak MM; Mogil'naia VI; Perstenev SV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(10):37-42. PubMed ID: 19008850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical rehabilitative effect of memantine on cognitive and motor disorders in patients with Parkinson's disease].
    Li W; Zhao JH; Sun SG; Zhang JW; Suo AQ; Ma MM
    Zhonghua Yi Xue Za Zhi; 2011 Feb; 91(5):301-3. PubMed ID: 21419002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Akatinol memantine in the therapy of cognitive disorders in Parkinson's disease].
    Puzin MN; Krivonos OV; Kozhevnikova ZhV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(1):26-9. PubMed ID: 17310793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of 12-week open-label memantine treatment on cognitive function improvement in patients with alcohol-related dementia.
    Cheon Y; Park J; Joe KH; Kim DJ
    Int J Neuropsychopharmacol; 2008 Nov; 11(7):971-83. PubMed ID: 18346293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy and safety of galantamine (reminyl) in the treatment of dementia in patients with Parkinson's disease (open-label controlled trial)].
    Litvinenko IV; Odinak MM; Mogil'naia VI; Emelin AIu
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(12):25-33. PubMed ID: 18427456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of galantamine (reminyl) for dementia in patients with Parkinson's disease (an open controlled trial).
    Litvinenko IV; Odinak MM; Mogil'naya VI; Emelin AY
    Neurosci Behav Physiol; 2008 Nov; 38(9):937-45. PubMed ID: 18975103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Memantine can relieve certain symptoms in Parkinson disease. Improvement achieved in two out of three described cases with dyskinesia and cognitive failure].
    Lökk J
    Lakartidningen; 2004 Jun; 101(23):2003-6. PubMed ID: 15232837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial.
    Aarsland D; Ballard C; Walker Z; Bostrom F; Alves G; Kossakowski K; Leroi I; Pozo-Rodriguez F; Minthon L; Londos E
    Lancet Neurol; 2009 Jul; 8(7):613-8. PubMed ID: 19520613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma homocysteine levels in patients treated with levodopa: motor and cognitive associations.
    Ozer F; Meral H; Hanoglu L; Aydemir T; Yilsen M; Cetin S; Ozturk O; Seval H; Koldas M
    Neurol Res; 2006 Dec; 28(8):853-8. PubMed ID: 17288745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy of memantine in Parkinson's disease with dementia].
    Levin OS; Batukaeva LA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(12):16-23. PubMed ID: 19156121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Multi-center open comparative randomized study of efficacy and safety of Akatinol Memantine 20 mg (single-doses) vs Akatinol Memantine 10 mg (double-doses) in patients with vascular dementia].
    Gavrilova SI; Kolykhalov IV; Mikhaylova NM; Ponomareva EV; Fedorova YB; Medvedev VE; Frolova VI; Gushanskaya EV; Litvinenko IV; Emelin AY; Lobzin VY; Kashin AV; Tanashyan MM; Kachanova MV; Knyazev AV; Gonik MI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2024; 124(2):69-77. PubMed ID: 38465812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Memantine effects measured with the Relevant Outcome Scale for Alzheimer's disease in an open-label, single-arm, multicenter clinical study.
    Holthoff V; Ferris S; Gauthier S; Ihl R; Robert P; Winblad B; Sternberg K; Tennigkeit F;
    Int J Geriatr Psychiatry; 2013 Feb; 28(2):164-72. PubMed ID: 22492589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive, psychiatric and motor response to galantamine in Parkinson's disease with dementia.
    Aarsland D; Hutchinson M; Larsen JP
    Int J Geriatr Psychiatry; 2003 Oct; 18(10):937-41. PubMed ID: 14533126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life and the effect of memantine in dementia with lewy bodies and Parkinson's disease dementia.
    Larsson V; Engedal K; Aarsland D; Wattmo C; Minthon L; Londos E
    Dement Geriatr Cogn Disord; 2011; 32(4):227-34. PubMed ID: 22122992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study.
    Stocchi F; Rascol O; Destee A; Hattori N; Hauser RA; Lang AE; Poewe W; Stacy M; Tolosa E; Gao H; Nagel J; Merschhemke M; Graf A; Kenney C; Trenkwalder C
    Mov Disord; 2013 Nov; 28(13):1838-46. PubMed ID: 23853029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperhomocysteinemia in levodopa-treated patients with Parkinson's disease dementia.
    Zoccolella S; dell'Aquila C; Abruzzese G; Antonini A; Bonuccelli U; Canesi M; Cristina S; Marchese R; Pacchetti C; Zagaglia R; Logroscino G; Defazio G; Lamberti P; Livrea P
    Mov Disord; 2009 May; 24(7):1028-33. PubMed ID: 19353704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies: systematic review with meta-analysis and trial sequential analysis.
    Wang HF; Yu JT; Tang SW; Jiang T; Tan CC; Meng XF; Wang C; Tan MS; Tan L
    J Neurol Neurosurg Psychiatry; 2015 Feb; 86(2):135-43. PubMed ID: 24828899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral effects of memantine in Alzheimer disease patients receiving donepezil treatment.
    Cummings JL; Schneider E; Tariot PN; Graham SM;
    Neurology; 2006 Jul; 67(1):57-63. PubMed ID: 16832078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of levodopa on cognitive function in Parkinson's disease with and without dementia and dementia with Lewy bodies.
    Molloy SA; Rowan EN; O'Brien JT; McKeith IG; Wesnes K; Burn DJ
    J Neurol Neurosurg Psychiatry; 2006 Dec; 77(12):1323-8. PubMed ID: 16952917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.